RC
Ramesh Chand Jain
About Ramesh Chand Jain
Data last updated:
Ramesh Chand Jain is a Director at Pharma Synth Formulations Limited (since 1993). The companies operate in Pharma. Pharma Synth Formulations Limited reported revenue of ₹53.06 Cr (FY 2024). Earlier, Ramesh Chand Jain was a Director at Apm Research & Analytical Labs Private Limited (from 2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Nov 1993 | 1993 | ₹53.06 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 26 Jul 2010 | 2010 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramesh Chand Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arvind Kumar Gupta | 00787256 | Pharma Synth Formulations Limited | Director |
| Phoolwati Jain | 00596821 | Pharma Synth Formulations Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Chand Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Chand Jain
Ramesh Chand Jain currently holds 1 directorship: Pharma Synth Formulations Limited (Director, since 26 Nov 1993, revenue ₹53.06 Cr (FY 2024)).
Ramesh Chand Jain was first appointed on 26 Nov 1993 as Director at Pharma Synth Formulations Limited. The most recent appointment on record is 26 Jul 2010 at Apm Research & Analytical Labs Private Limited.
Ramesh Chand Jain held 1 earlier board appointment: Apm Research & Analytical Labs Private Limited (Director, from 26 Jul 2010).
The current boards of Ramesh Chand Jain's companies include Arvind Kumar Gupta (Pharma Synth Formulations Limited), Phoolwati Jain (Pharma Synth Formulations Limited).